CLINICAL DEVELOPMENT AND MANUFACTURING AGREEMENT BETWEEN BIOGEN INC. AND VIR BIOTECHNOLOGY, INC. DATED May 22, 2020Clinical Development and Manufacturing Agreement • June 23rd, 2020 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 23rd, 2020 Company Industry JurisdictionThis Clinical Development and Manufacturing Agreement (“Agreement”) is made as of this 22nd day of May, 2020 (“Effective Date”), by and between Vir Biotechnology, Inc., a Delaware corporation, having a place of business at 499 Illinois Street, Suite 500, San Francisco, CA 94158 (“Vir”) and Biogen Inc., a Delaware corporation, having a place of business at 225 Binney Street, Cambridge, MA 02142 (“Biogen”).